FundedIQ
Artificial Intelligence

MedFacts: Funding, Investors & Team (Sep 2026)

MedFacts is a pioneering AI technology development company that leverages proprietary AI-driven platforms to accelerate the discovery and development of novel drugs. Utilizing self developed advanced technologies like MedGEN, MedBIO, MedTOX, and MedDOCK, MedFacts enhances the precision, efficiency, and effectiveness of drug discovery processes. The company focuses on addressing critical gaps in the treatment of antibiotic-resistant infections, with a strong commitment to meeting unmet medical needs and developing sustainable therapeutic solutions. MedFacts is at the forefront of combating bacterial resistances, driving innovation in pharmaceutical development to deliver next-generation antibiotics to the market.

www.medfacts.pt LinkedIn Lisbon, Portugal 1-10 employees
Generative AI Pharmaceutical
Total raised
$50k
Rounds
1
Latest
Pre-Seed
Dec 2024

MedFacts has raised $50k across 1 funding round on record, the most recent a Pre-Seed of $50k announced in Dec 2024.

That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

MedFacts Company Profile and Key Stats

Total funding raised
$50k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$50k in Dec 2024
Employees
1-10
reported band
Headquarters
Lisbon, Portugal

Latest funding round on record: Dec 2024.

MedFacts Funding Rounds

Date
Round
Amount
Pre-Seed
$50k

MedFacts Founders and Leadership Team

Name
Role
Contact
Bruno Macedo
Founder

No contact details are on record for this team yet.

MedFacts Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round
127
$2.7M
5,801
$600K

MedFacts' latest round of $50k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MedFacts in Artificial Intelligence and Lisbon

Companies Similar to MedFacts

Coalex.ai is a human-in-the-loop AI platform that helps enterprises deploy auditable, self-improving AI…

Seed $60k

AI agent that responds on WhatsApp, Telegram and your website — naturally, even with real voice — turning…

Undisclosed round $10k

Dojo AI is pioneering the Marketing Operating System (MOS) category, providing challenger brands with…

Seed $6.0M

Dojo AI is pioneering the Marketing Operating System (MOS) category, providing challenger brands with…

Pre-Seed $1.0M

Sensei is changing the way the world shops through custom retail experiences designed for humans that…

Series A $16.0M

Pluggable is the leading solution for meaningful fan engagement, using Artificial Intelligence and…

Seed $1.9M

Eneida specializes in creating smart sensors and artificial intelligence tools for robust and flexible low…

Series B $11.4M

Sports and Events organizations possess a vast quantity of data, but the dilemma lies in how to utilize it…

Seed $2.2M

AssetFloow is a unique type of artificial intelligence software that can gather data on customer behavior…

Undisclosed round $1.6M

Visor.ai is a platform for Customer Service teams that are not proficient in technical skills, which utilizes…

Undisclosed round $4.7M

Smartex addresses key issues affecting the world's textile supply chain. Our AI-based solutions are removing…

Series A $24.7M
Series A $7.2M

MedFacts Funding FAQs

What does MedFacts do?

MedFacts is a pioneering AI technology development company that leverages proprietary AI-driven platforms to accelerate the discovery and development of novel drugs. Utilizing self developed advanced technologies like MedGEN, MedBIO, MedTOX, and MedDOCK, MedFacts enhances the precision, efficiency, and effectiveness of drug discovery processes. The company focuses on addressing critical gaps in the treatment of antibiotic-resistant infections, with a strong commitment to meeting unmet medical needs and developing sustainable therapeutic solutions. MedFacts is at the forefront of combating bacterial resistances, driving innovation in pharmaceutical development to deliver next-generation antibiotics to the market.

How much funding has MedFacts raised?

MedFacts has raised $50k across 1 round on record. The most recent is a Pre-Seed of $50k announced in Dec 2024.

When did MedFacts last raise funding?

MedFacts' most recent funding round on record is a Pre-Seed of $50k, announced in Dec 2024.

Who founded MedFacts?

FundedIQ lists Bruno Macedo (Founder) at MedFacts.

Where is MedFacts headquartered?

MedFacts is based in Lisbon, Lisboa, Portugal.

How many employees does MedFacts have?

MedFacts is in the 1-10 employee band.

How does MedFacts' funding compare to other Artificial Intelligence startups?

MedFacts' latest round of $50k is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's MedFacts Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MedFacts is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.